NCI Standard Funding Opportunity Announcements
|
|
Current and Recent
Program Announcements |
Current and Recent
Requests for Applications |
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates
|
|
| Rolling |
All Faculty |
Non-federal |
Clinical Studies |
Investigator-initiated Research Grants
Supports innovative and unique clinical trials that have the potential to
immediately impact the lives of cancer patients in a positive
way. Looking for outstanding clinical treatment ideas and are
driven to deliver new and better treatment options by designing
novel, new, and/or pilot projects distinctly removed from
currently funded research projects.
|
|
| March 01 |
Graduate Students |
Non-federal |
Bone Marrow Failure |
Aplastic Anemia & MDS International Foundation (AA&MDSIF)
Summer Fellowship Grant Program
Will offer students an opportunity to engage in research under
the supervision of an established institution Students will
learn valuable skills, gain experience and develop an interest
in the science of bone marrow failure disease
| Due Dates: |
February 26 (OSR) Ι March 1 (Sponsor) |
| Amount & Project Period: |
$5,000 - 10 week fellowship for the summer of
2015 |
| Eligibility: |
Medical students and graduate students, in the
biological sciences currently enrolled in a U.S. graduate program in the
biomedical sciences, medical school or in an MD/PhD program |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
Summer Fellowship Program Application |
|
|
| March 01 |
See Below |
Non-federal |
Melanoma |
Melanoma Research Foundation - 2015 Research Awards
Career Development Awards
Researchers who are beginning a research career focused on
melanoma and have not yet established strong federal funding for
their research are eligible. Use of relevant genetic models
and human derived tumor samples is highly encouraged
| Amount & Project Period: |
$50,000/yr. - 2 years |
| Eligibility: |
Postdocs & Jr. Faculty |
Established Investigator Awards (EIA)
To established melanoma researchers, or senior researchers
working in closely related fields wishing to move into melanoma
research. Use of relevant genetic models and human derived
tumor samples is highly encouraged.
| Amount & Project Period: |
$100,000/year - 2 years |
| Eligibility: |
Associate Professor or higher |
2015 Team Awards
Teams of basic scientists and clinicians to address an
unmet clinical need Use of relevant genetic models and human
derived tumor samples is required. Must address 1 of the
Specific Topic Proposals (STPs) identified below:
1. Prevention: Development of models and biomarkers.
2. Identifying mechanisms and respective therapeutic strategies
in less common molecular subsets of melanoma.
3. Metastases: Dormancy and metastatic progression.
4. CNS Metastases: Development of markers of risk and
rational therapeutic approaches.
5. Response to treatment: Mechanisms and respective
biomarkers for predicting response and for monitoring
therapeutic response.
6. Resistance: Intrinsic/Innate/Primary resistance to
immunotherapies in melanoma.
| Amount & Project Period: |
$250,000/year - 2 years |
| Eligibility: |
Associate Professor or
higher |
|
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
| March 02 (LOI) |
All Faculty |
Federal |
Pancreatic |
Consortium for the Study of Chronic Pancreatitis, Diabetes and
Pancreatic Cancer Clinical Centers (CSCPDPC -CCs)
For
establishment of up to 9 Clinical Centers
(CC), to conduct studies on chronic pancreatitis (CP) and
factors that increase risk of pancreatic cancer in patients
(children and adults) with CP, pancreatogenic (type 3c) diabetes
(T3cDM) and in patients with newly diagnosed diabetes.
| Due Dates: |
March 02 (Letter of Intent) Ι
March 31 (OSR) Ι April 02 (Sponsor) |
| Amount & Project Period: |
$270,000/year (Direct Costs) - 5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-DK-14-027 |
|
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
| March 02 (LOI) |
All Clinical Faculty |
Federal |
Pancreatic |
Consortium for the Study of Chronic Pancreatitis, Diabetes
and Pancreatic Cancer: Coordination and Data Management Center
(CSCPDPC- CDMC)
For establishment of Coordination and
Data Management Center (CDMC) for up to 9 Clinical Centers (CC),
to conduct studies on chronic pancreatitis (CP) and factors that
increase risk of pancreatic cancer in patients (children and
adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and
in patients with newly diagnosed diabetes.
| Due Dates: |
March 02 (LOI) Ι March
31 (OSR) Ι April 02 (Sponsor) |
| Amount & Project Period: |
$1M (Direct Costs) - 5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-DK-14-028 |
|
| Cooperative Agreement |
ONC/DHHS |
Office of the National Coordinator of Health Information
Technology
NEW
|
| March 02 (LOI) |
All Ranks |
Federal |
Community Health |
Office of the National Coordinator of Health Information
Technology
Community Health Peer Learning Program (CHP)
The purpose is to address health challenges at the population
level through a community-based collaborative approach. During
initial phase of program, awardee will release a call for
applications to identify and select up to ten (10) communities
across the care management continuum to participate in the CHP.
During second phase, selected communities will complete a peer
learning program
ONC will conduct an informational session to provide
information related to this FOA. Further details -
including date, time, and instructions for joining - are
available at:
http://healthit.gov/newsroom/community-health-peer-learning-program
| Due Dates: |
March 02
(Letter of Intent)
Applications: April 02 (OSR) Ι April 06 (Sponsor) |
| Amount & Project Period: |
$1,700,000 - 2 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda Nolan (x6071) |
| RFA Link: |
CLP-CL-15-001 |
|
|
| March 03 (LOI) |
All Ranks |
Non-federal |
HIV |
amfAR, The Foundation for AIDS Research
Impact Grants Exploring HIV Persistence and Eradication
Availability of funding to support research relevant to
exploring HIV persistence and the potential for HIV eradication
Priority will be given to projects with a clear pathway to
development of an implementable intervention in humans Impact
Grants support in-depth development of concepts where
preliminary data have indicated genuine promise in curing HIV
and should include basic, animal and clinical (in vivo or ex
vivo) research, and collaborations with other institutions.
Must request log-in
credentials no later than 3:00 PM ET on Friday, February 27,
2015.
| Due Dates: |
March 03 (Letter of Intent)
Hardcopy of Signed Face Page By Mail: Tuesday, March 24, 2015
Invited Applications: March 26 (OSR) Ι March 30 (Sponsor) |
| Amount & Project Period: |
$2,000,000 (TOTAL) - 4 years |
| Eligibility: |
Must hold a doctoral-level degree
Must hold a faculty-level position
Must be affiliated with the applicant institution |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFP |
|
NEW |
| March 06 (LOI) |
Postdocs/Jr. Faculty |
Non-federal |
Career Development |
Thrasher Research
Fund
Early Career Awards
To encourage development of medical research in child health by awarding
small grants to new researchers The Fund is open to a variety
of research topics important to children's health. Both
incidence and severity are considered when determining the
significance of a problem being studied.
| Due Dates: |
March 06 (Noon MST) Concept Paper
Invited Submissions: April 16 (OSR) Ι April 20 (Sponsor) |
| Amount & Project Period: |
$25,000 - 1 year |
| Eligibility: |
Post-doctoral
researchers who received doctoral degree <3 years prior to
date of submission of Concept Paper
Physicians in
residency/fellowship training program, or completed that program <1 year
before date of submission of Concept Paper
A new investigator holding an
NIH K award or a Clinical and Translational Science Award (CTSA) is not
eligible
Each applicant must have a
mentor. Qualifications and experience of the mentor will be considered
in evaluating the application. There are no restrictions with regard to
citizenship. |
| Contact: |
Linda
Nolan (x6071) |
| Link: |
Early Career Award Guidelines |
|
|
| March 06 |
All Ranks |
Federal |
Translation of Technologies |
Academic-Industrial Partnerships for Translation of
Technologies for Cancer Diagnosis and Treatment
Encourages applications from research partnerships formed by academic and
industrial investigators, to accelerate translation of
technologies, methods, assays or devices, and/or systems for
preclinical or clinical molecular diagnosis or in vitro imaging
designed to solve a targeted cancer problem Will support
clinical trials that test functionality, optimize, and validate
the performance of the proposed translational work.
| Due Dates: |
March 04 (OSR) Ι March 06
(Sponsor) |
| Amount & Project Period: |
Budgets are not limited - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-15-075 |
|
Spring 2015 Cycle
|
| March 06 (LOI) |
All Ranks |
Non-federal |
PCOR |
Patient-Centered Outcomes Research
Institute Spring Cycle 2015
| Due Dates: |
March 06 (Letter of Intent)
Applications: May 01 (OSR) Ι May 05 (Sponsor) |
| Eligibility: |
All Ranks |
| Contact: |
Scott
Mears - 1397 |
Improving Methods for Conducting Patient-Centered
Outcomes Research
To address gaps in methodological research relevant to
conducting patient-centered outcomes research (PCOR)
Addressing Disparities
To fund comparative effectiveness research (CER) studies
evaluating or comparing new and/or enhanced interventions to
reduce or eliminate disparities in health and healthcare.
Studies should focus on overcoming barriers that may
disproportionately affect outcomes of specific groups of
patients, or identify best practices for sharing results and
information about patient-centered research across patient
groups.
Communication and Dissemination Research
For projects addressing critical knowledge gaps in communication and
dissemination - of research results to patients, caregivers, and
clinicians, as well between patients, caregivers, and clinicians
Assessment of Prevention, Diagnosis, and Treatment Options
To provide information that would inform critical decisions that
face patients and caregivers, clinicians, policy makers, and
healthcare system leaders. These decisions must be consequential
and be occurring now in the absence of sound evidence about the
comparative effectiveness of alternative approaches
Improving Healthcare Systems
To study comparative effectiveness of alternate features of
healthcare systems (e.g., innovative technologies, incentive
structures, service designs) intended to optimize quality,
outcomes, and/or efficiency of care for patients served, and
have most potential for sustained impact and replication within
and across healthcare systems
Large Pragmatic Studies to Evaluate Patient-Centered
Outcomes
|
NCI is a participating Institute
NEW |
| March 07 (LOI) |
All Ranks |
Federal |
BDK2 |
NIH Big Data to Knowledge (BD2K) Enhancing Diversity in
Biomedical Data Science
To support educational activities that will enhance diversity of
the biomedical, behavioral, and clinical research workforce.
FOA will support creative educational activities with a primary
focus on research experiences and curriculum development
| Due Dates: |
March 07 (Letter of Intent)
Applications: April 03 (OSR) Ι April 07 (Sponsor) |
| Amount & Project Period: |
$200,000/year (Direct Costs) - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-MD-15-005 |
|
&
|
| March 09 |
Postdocs |
Non-federal |
Career Development |
Society for Immunotherapy of Cancer - in partnership with
Merck
2015 SITC-Merck Cancer Immunotherapy Clinical Fellowship
Award
Funding support for a project in related to development and
application of cancer immunotherapy in a unique clinical
research area
| Due Dates: |
March 5 (OSR) Ι March 09 (Sponsor) |
| Amount & Project Period: |
$100,000 - 1 year |
| Eligibility: |
MD or combined MD/PhD degree as a postdoc,
resident, research scientist or comparable position
SITC member in good standing at time of Submission
75% effort for this project |
| Contact: |
Linda
Nolan (X6071) |
| Link: |
Fellowship Information |
|
|
| March 09 |
All Ranks |
Federal |
Multi-scale Models |
Predictive Multiscale Models for Biomedical, Biological,
Behavioral, Environmental and Clinical Research
NCI is interested in supporting development of predictive
multi-scale models of cancer processes. Models may be
designed to elucidate basic mechanisms underlying cancer
initiation and progression and/or address important
translational, clinical or epidemiological questions related to
cancer risk, prevention, diagnosis and treatment.
| Due Dates: |
Letter of Intent due 30 days prior to due date
March 05 (OSR) Ι March 09 (Sponsor) |
| Amount & Project Period: |
<$500,000/year
(Direct Costs) - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-15-085 |
|
NCI is a participating Institute
NEW |
| March 14 (LOI) |
All Ranks |
Federal |
Brain Cognitive Development |
Adolescent Brain Cognitive Development (ABCD) Study
(3 Funding Opportunity Announcements)
| Due Dates: |
March 14 (Letter of Intent)
Applications: April 10 (OSR) Ι April 14 (Sponsor)
|
| Amount & Project Period: |
Budgets are not limited – 5 years |
| Contact: |
Linda
Nolan
(x6071) |
Coordinating
Center
FOA solicits applications for an overall Coordinating Center to
provide organizational framework for management, direction, and
overall coordination of national multi-site consortium. Will
coordinate interactions of individual Research Project Sites and
Data Analysis and Informatics Center. Coordinating Center will
be responsible for standardization of protocols, training of
staff, and testing of inter-rater reliability of core
neuropsychological, clinical, and other phenotypic assessments
to make sure administration of these measures is consistent
across research sites.
| Eligibility: |
All Ranks - PI/PD should have
multidisciplinary expertise and working knowledge of resources, methods,
and logistics required in support of the objective and research
questions described in the FOA. Minimum effort for a single PD/PI is
35% effort per year, and if MPIs, each multi-PD/PI must commit at least
20% per year. Consortium Coordinator(s) cannot be PD/PI on another
component of consortium |
| RFA Link: |
RFA-DA-15-014
|
|
|
Research Project Sites
Multi-site research project sites from a group of investigators
(both w/in and across institutions) or from a single site whose
scientific and technical expertise will allow them to address
the objective and research questions described in RFA
Research
project site will be responsible for subject recruitment &
retention, behavioral assessments, biospecimen collection, and
neuroimaging. In addition to addressing primary objective of
consortium, each research project site will be allowed to pursue
additional aims and objectives provided they remain secondary to
overall consortium objective
| Eligibility: |
All Ranks - supports, but does not require,
linked applications |
| RFA Link: |
RFA-DA-15-015 |
|
|
Data Analysis and Informatics Center
The Collaborative Research on Addiction at the NIH (CRAN)
intends to jointly fund the Adolescent Brain Cognitive
Development (ABCD) Study Consortium. This FOA solicits
applications for one central Data Analysis and Informatics
Center (DA&IC) to coordinate and centralize the data analysis,
integration, harmonization, sharing, and informatics across
research project sites in support of the objective and research
questions described in FOA The DA&IC will oversee and manage
standardization of data collection procedures; provide technical
support; ensure quality control; perform integrative data
analysis; and coordinate data storage and data sharing
activities.
|
NEW |
| March 15 (Concept Paper) |
All Ranks |
Non-federal |
Pembrolizunab |
Oncology Merck Investigator Studies Program (MISP) Concept
Proposals
1. Novel regimens using pembrolizumab
2. Maintenance(Pembrolizumab post induction with BRAF/MEK, etc.)
3. Observational studies evaluating or assessing characteristics of
patients treated
w/pembrolizumab
4. Studies that describe innovative programs and methods for studying
survivorship of
patients
5. Studies that identify, from patient's perspective, cancer symptoms
of greatest importance in
patients with advanced cancers
|
NEW |
| March 16 (Pre-app) |
All Ranks |
Non-federal |
Healthcare-Vulnerable Populations |
Rita and Alex Hillman Foundation
Innovations in Care
To advance leading edge, nursing driven models of care that will
improve health and health care of vulnerable populations,
including economically disadvantaged, racial & ethnic
minorities, LGBQT, homeless, rural populations, and other groups
that encounter barriers to accessing health-care services.
| Due Dates: |
March 16 (Pre-application)
Invited Submissions: June 11 (OSR) Ι June 15 (Sponsor) |
| Amount & Project Period: |
$600,000 (Total) - 3 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
Overview Ι
RFP |
|
|
| March 17 |
Postdocs |
Non-federal |
Career Development |
Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award
Supports all theoretical and experimental research relevant to the study
of cancer and the search for cancer causes, mechanisms,
therapies and prevention
| Due Dates: |
March 12 (OSR) Ι March 16 by 4:00pm(Sponsor) |
| Amount & Project Period: |
Level I Funding:
$50,000/year plus $2,000 for expenses
Level II Funding: $60,000/year plus $2,000 for expenses
Award duration: 3 years |
| Eligibility: |
Degree conferred April 15, 2014
- March 16, 2015 (MD, PhD, MD/PhD, DDS, DVM or equiv.)
Foreign candidates may apply to do research only in the US |
| Contact: |
Linda
Nolan (X6071) |
| Link: |
Fellowship Award Application Guidelines |
|
NEW
|
| March 17 (Pre-app) |
Established Investigators |
Non-federal |
Myelodysplastic Syndromes |
Taub Foundation
Grants program for MDS Research
High-impact, innovative translational research on underlying
causes of MDS and advancement of treatment & prevention.
Program specifically focuses on MDS research, exclusive of AML
and MPN Studies focusing on molecular genetics, epigenetics,
splicing factors, stem cells, the microenvironment and novel
therapeutic targets relevant to MDS are encouraged
| Due Dates: |
March 13 (OSR) Ι March 17 (Sponsor)
Full applications will be invited and due mid-August |
| Amount & Project Period: |
$200,000/year (Total) - 3 years |
| Eligibility: |
Independent investigators w/institutional
support & laboratory space
U.S. citizenship not required; visa documentation not required |
| Contact: |
Linda
Nolan (x6071) |
| Link: |
Taub Foundation
Grants Program for MDS Research |
|
|
| March 17 |
Established Investigators |
Non-federal |
Multiple Myeloma |
Multiple Myeloma Research Foundation (MMRF)
Senior Research Awards
To accelerate development of therapeutic approaches for myeloma;
may include proposals in basic science, validation, or clinical
research
| Due Dates: |
March 13 (OSR) Ι March 17
(Sponsor) |
| Amount & Project Period: |
$100,000/year (TOTAL) - 2 years |
| Eligibility: |
Established Investigators
w/documented experience in blood cancer research or in research areas
that are pertinent to multiple myeloma |
| Contact: |
Linda
Nolan (x6071) |
| Links: |
MMRF Research Grants Ι
2015 Program Guidelines |
|
|
|
| March 17 |
All Ranks |
Federal |
Molecular Analysis Technology |
Innovative Molecular Analysis Technologies for Cancer
Research
Emphasis of this FOA is on supporting development of novel
molecular and cellular analysis capabilities with a high degree
of technical innovation with potential to significantly affect
and transform investigations exploring molecular and cellular
basis of cancer
| Due Dates: |
March 13 (OSR) Ι March 17 (Sponsor)
Letter of Intent due 30 days prior to due date |
| Amount & Project Period: |
$400,000 (Direct Costs) - 3 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-CA-15-002 |
|
|
| March 17 |
All Ranks |
Federal |
Molecular Analysis Technology |
Advanced Development and Validation of Emerging Molecular
Analysis Technologies for Cancer Research
Projects on advanced development of emerging molecular and
cellular analysis technologies and validation in an appropriate
cancer-relevant biological system Proof-of-principle of proposed
technology or methodology has been established and supportive
preliminary data are available Proposal should reflect
potential to produce a molecular analysis technology with a
major impact in cancer-relevant research
| Due Dates: |
March 13 (OSR) Ι March 17 (Sponsor)
Letter of Intent due 30 days prior to due date |
| Amount & Project Period: |
$300,000/year (Direct Costs) - 3 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-CA-15-003 |
|
|
| March 17 |
All Ranks |
Federal |
Biospecimen Science |
Innovative Technologies for Cancer-Relevant Biospecimen Science
Projects on the inception and early-stage development of
technologies addressing issues related to pre-analytical
degradation of targeted analytes during collection, processing,
handling, and storage of cancer-relevant biospecimens
| Due Dates: |
March 13 (OSR) Ι March 17 (Sponsor)
Letter of Intent due 30 days prior to due date |
| Amount & Project Period: |
$400,000 (Direct Costs) - 3 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-CA-15-004 |
|
|
| March 17 |
All Ranks |
Federal |
Biospecimen Science |
Advanced Development and Validation of Emerging Technologies
for Cancer-Relevant Biospecimen Science
Projects on advanced development and validation of technologies
addressing issues related to pre-analytical degradation of
targeted analytes during collection, processing, handling, and
storage of cancer-relevant biospecimens
| Due Dates: |
March 13 (OSR) Ι March 17 (Sponsor)
Letter of Intent due 30 days prior to due date |
| Amount & Project Period: |
$300,000/year (Direct Costs) - 3 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-CA-15-005 |
|
NEW |
| March 18 |
Postdocs |
Non-federal |
Career Development |
Robert Wood Johnson Foundation
Harold Amos Medical Faculty Development Program
Postdoctoral research awards to increase the number of faculty
from historically disadvantaged backgrounds who 1) can achieve
senior rank in academic medicine and 2) who will encourage and
foster the development of succeeding classes of such physicians.
| Due Dates: |
March 16 (OSR) Ι March 18 (Sponsor) |
| Amount & Project Period: |
$105,000/year - 4 years |
| Eligibility: |
From historically disadvantaged backgrounds
(ethnic, financial or educational),
U.S. citizens or permanent residents, and
Completing or have completed formal clinical training. (Preference to
those having recently completed formal clinical training)
Must spend at least 70% time engaged in research |
| Contact: |
Linda
Nolan (x6071) |
| Links: |
2015 Call for Applications Ι
MyRWJF |
|
NEW |
| March 18 |
Jr Faculty |
Non-federal |
Stem Cell Research |
The New York Stem Cell Foundation
Innovator Awards for Early Career Investigators in
Neuroscience
Applications are encouraged in the fundamental areas of
developmental, cellular, cognitive and behavioral neuroscience,
broadly interpreted.
| Due Dates: |
March 16 (OSR) Ι March 18 (Sponsor) |
| Amount & Project Period: |
$300,000/year - 5 years |
| Eligibility: |
Early career investigators - Must have terminal
degree; Must be w/in 5 years of 1st faculty appointment (as of 6/1/15);
Must have publication record of innovation and high impact |
| Contact: |
Linda
Nolan (x6071) |
| Links: |
Overview Ι
RFP |
|
|
NEW |
Innovator Awards for Early Career Investigators in
Translational Stem Cell Research
Exploring the basic biology and translational potential of stem
cells and advancing understanding and use of stem cells in the
development of treatments for human disease
| Due Dates: |
March 16 (OSR) Ι March 18 (Sponsor) |
| Amount & Project Period: |
$300,000/year - 5 years |
| Eligibility: |
Early career investigators - Must have terminal
degree; Must be w/in 5 years of 1st faculty appointment (as of 6/1/15);
Must have publication record of innovation and high impact |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
Overview Ι
RFP |
|
NEW |
| March 18 |
Postdocs |
Non-federal |
Bladder Cancer |
Bladder Cancer Advocacy Network (BCAN)
John Quale Travel Fellowships
Opportunity for early career investigators interested in bladder
cancer research to attend the annual Bladder Cancer Think Tank
Meeting August 6-8, 2015 in Charlotte, North Carolina The
primary mission of this meeting is to enhance collaboration
among physicians and researchers dedicated to the prevention,
diagnosis, and treatment of bladder cancer
| Due Dates: |
March 18 (via
Proposal Central) |
| Amount & Project Period: |
$1,700 for travel-related costs |
| Eligibility: |
MDs & PhDs at post-graduate, pre-faculty level
(not begun a faculty appointment as of April 14. MDs must be in final
year of residency or in a fellowship program. PhDs must be postdoctoral
fellows. |
| Contact: |
Linda
Nolan (x6071) |
| Links: |
Application-Instructions Ι
BCAN
|
|
|
| March 19 |
Jr Faculty |
Non-federal |
Brain Cancer |
The Sontag Foundation
2015 Distinguished Scientist Awards
For early career scientists with the potential to create new waves across
the brain cancer field Research focus on increased survival
rates and improved recovery for patients and a cure or at the
very least, treatments to make brain cancer a manageable chronic
disease
| Due Dates: |
March 17 (OSR) Ι March 19 (12:00pm -
Sponsor) |
| Amount & Project Period: |
$150,000/yr - 4 years |
| Eligibility: |
Junior faculty in their first independent,
full-time faculty appointment (appointed no earlier than March 1, 2012) |
| Contact: |
Linda
Nolan (X6071) |
| Link: |
Applying for
the Distinguished Scientist Award |
|
|
| March 20 |
All Faculty |
Federal |
Clinical Collaborations |
Opportunities for Collaborative Research at the NIH Clinical
Center
NCI encourages bench-to-bedside
research to: increase understanding of molecular and
physiological basis of health and disease; stimulate clinical
discoveries about mechanisms underlying disease to develop
improved prevention, diagnosis, and treatment; enable
translation of basic discoveries into clinical practice to
benefit personal and public health; foster training and
mentoring of emerging scientists and physicians; and communicate
research advances to the public.
| Due Dates: |
March 18 (OSR) Ι March 20
(Sponsor) |
| Amount & Project Period: |
$500,000/year (Direct Costs) - 3 years
(includes Clinical Center costs and intramural investigator's costs
attributed to proposed research*)
*NIH Clinical Center
costs and intramural investigator's costs will not be included in the
award paid to the grantee |
| Eligibility: |
All Faculty - application must include at least
one intramural scientist as Program Director/Principal Investigator or
collaborator, and some of the research must be conducted at the NIH
Clinical Center |
| Contact: |
Linda Nolan (x6071) |
| FOA Link: |
PAR-13-358 |
|
|
Phase Innovation Awards Cooperative Agreement
|
| March 26 |
All Ranks |
Federal |
Assay Validation |
Assay Validation For High Quality Markers For NCI-Supported
Clinical Trials
UH2 Phase supports analytical validation of assays for markers that must
be achieved in 2 years before an assay may undergo clinical
evaluation
| Due Dates: |
March 24 (OSR) Ι March 26
(Sponsor) Letter of Intent due 30 days prior to due date |
| Amount & Project Period: |
$275,000 (Direct Costs) - UH2 phase (2 years)
|
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-15-095 |
|
|
Exploratory/Developmental Cooperative Agreement
Phase II
|
| March 26 |
All Ranks |
Federal |
Assay Validation |
Assay Validation For High Quality Markers For NCI-Supported
Clinical Trials
The UH3 mechanism supports clinical validation of established
assays for up to 3 years using specimens from retrospective or
prospective studies w/purpose of developing assays to a point
where their clinical utility could be assessed in other trials.
| Due Dates: |
March 24 (OSR) Ι March 26 (Sponsor)
Letter of Intent due 30 days prior to due date
|
| Amount & Project Period: |
$250,000/year (Direct Costs) - UH3 phase (3
years) |
| Eligibility: |
All Ranks |
| Contact: |
Linda Nolan (x6071) |
| FOA Link: |
PAR-15-096 |
|
|
| March 27 |
Jr Faculty |
Non-federal |
Radiation Oncology |
American Society for Radiation Oncology
| Due Dates: |
March 25 (OSR) Ι March 27
(Sponsor) |
| Contact: |
Linda
Nolan (x6071) |
Comparative Effectiveness Research Award
To stimulate research focused on evaluating the effectiveness,
complication profile, cost and cost-effectiveness of various
radiation therapy treatments, as well as the comparative
effectiveness when compared to other therapies.
| Amount & Project Period: |
$50,000/year - 2 years |
| Eligibility: |
Must be active members of ASTRO
Must be a board-certified or board-eligible physician or physicist in
radiation oncology or a radiobiologist at time of award
At least 40% full-time professional effort must be devoted to goals of
award |
| Links: |
Comparative Effectiveness Award
Award Requirements & Obligations |
Junior Faculty Career Research Training Award
Specific areas of interest may include:
(1) Basic and clinical
research in radiation therapy sciences; (2) Projects developing
innovative techniques, new methods or special equipment leading
to better patient care; (3) Aspects of health care planning and
delivery, including outcome evaluation; (4) Development of
programs in health education relevant to radiation therapy
sciences
| Amount & Project Period: |
$100,000/year - 2 years |
| Eligibility: |
Must be w/in first 3 years of Jr
Faculty appointment
Applicants & mentors must be active ASTRO members
At least 75% full-time professional effort must be devoted to goals of
award |
| Links: |
Jr Faculty Award Ι
Award Requirements and Obligations |
Seed Grant
Specific areas of interest may include: (1) Basic
and clinical research in radiation therapy sciences; (2)
Projects developing innovative techniques, new methods or
special equipment leading to better patient care; (3) Aspects of
health care planning and delivery, including outcome evaluation;
(4) Development of programs in health education relevant to
radiation therapy sciences
| Amount & Project Period: |
$25,000 - 1 year |
| Eligibility: |
Must be in a U.S. residency or fellowship
Mentors must be active members of ASTRO.
Must not have previously served as PI or co-PI on grants totaling
$50,000 or more in a single calendar year
At least 75% full-time professional effort must be devoted to goals of
award |
| Links: |
Seed Grant Guidelines Ι
Award Requirements & Obligations |
|
NEW |
| March 27 (LOI) |
All Faculty |
Federal |
Patient Safety |
Agency for Healthcare Quality and Research
Patient Safety Learning Laboratories: Innovative Design and
Development to Improve Healthcare Delivery Systems
For creation and utilization of Patient Safety Learning
Laboratories that will enable multiple develop-test-revise
iterations of promising design features and subsystems.
| Due Dates: |
March 27 (Letter of Intent)
Applications: April 23 (OSR) Ι April 27 (Sponsor) |
| Amount & Project Period: |
$1,000,000 (TOTAL) - 4 years |
| Eligibility: |
All Faculty - Only 1 PD/PI who must commit at
least 15% effort per year |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-HS-15-001 |
|
 |
| March 31 (LOI) |
All Ranks |
Non-federal |
Internatnl./Interdisciplinary Research |
Human Frontier Science Program
2016 Program and Young Investigator Grants
Program and Young Investigator Grants support innovative basic
research into fundamental biological problems w/emphasis on
novel & interdisciplinary approaches involving scientific
exchanges across national and disciplinary boundaries.
Applicants are expected to develop new lines of research through
collaboration
| Due Dates: |
March 31 (Letter of Intent)
Invited Submissions: Mid-September
Registration via
HFSP
extranet site is required by March 19th 2015 to obtain a reference
number (LIXXXXXX/2016) |
| Amount & Project Period: |
Team of >4: $450,000/year(Total) - 3 years
Team of 2: $250,000/year (Total) - 3 years
Team of 3: $350,000/year (Total) - 3 years
See addnl. funding information in Guidelines for Applicants |
| Eligibility: |
Common to
both Grants:
Must have "international research team
Team made up of "members", & 1 is designated as "Principal Applicant";
others: "Co-Applicants"
At least 1 member of international team must have laboratory in a
country other than that of the Principal Applicant
Research conducted w/in only 1 country not
eligible
Young Investigator:
All team members must be w/in 5 years of obtaining independent position
but first doctoral degree (PhD, MD or equivalent) <10 years before
deadline for letter of intent. Program Grants:
Principal Applicant must be in a position to initiate/direct independent
lines of research; have responsibility for a laboratory and show
evidence of independence |
| Contact: |
Linda
Nolan (x6071) |
| Links: |
Information and Guidelines Ι
Guidelines for Applicants |
|
NEW |
| April 01 |
All Ranks |
federal |
Cancer Epidemiology Cohorts |
Core
Infrastructure and Methodological Research for Cancer
Epidemiology Cohorts
Targeted infrastructure support of core functions of Cancer
Epidemiology Cohorts (CECs) and methodological research Will
support infrastructure and core functions for existing or new
CECs
| Due Dates: |
March 30 (OSR) Ι April 01
(Sponsor) Letter of Intent due 30 days prior to stated sponsor due
date |
| Amount & Project Period: |
$2.5M/year (Direct Costs) - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-15-104 |
|
|
|
| April 01 |
All Faculty |
Federal |
PCOR-Conference Support |
Patient-Centered Outcomes Research Institute
Engagement
Award (EAIN): Research Meeting and Conference Support
Available funding support for meetings and conferences that
align with PCORI's Mission and Strategic Plan and
facilitate expansion of patient-centered outcomes
research/clinical comparative effectiveness research (PCOR/CER)
Applicant Town Hall Sessions:
February 17th, 3:00 p.m. - 4:00 p.m. (ET)
| Due Dates: |
March 30 (OSR) Ι April 01 (Sponsor) |
| Amount & Project Period: |
One-time award: $50,000 (Total Costs) -1 year
Multi-year award: $250,000 (Total Costs) - 2 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda Nolan (x6071) |
| Link: |
Application Information |
|
Annual Due Date
|
| April 01 |
See Below |
Non-federal |
Career Development |
American Cancer Society
| Due Dates: |
Mar 30 (OSR) Ι Apr 01
(Sponsor-Electronic) Ι Apr 02 (Hardcopy) |
| Contact: |
Linda Nolan (x6071) |
Mentored Research Scholar Grant in Applied and Clinical Research
For beginning investigators to become independent as either
clinician scientists or cancer control and prevention
researchers.
|
|
|
Research Scholar Grants in Basic, Preclinical, Clinical and
Epidemiology Research
Supports investigator-initiated research projects in basic,
preclinical, clinical and epidemiologic research
| Amount & Project Period: |
$200,000/year (Direct Costs)* - 4 years |
| Eligibility: |
Must be independent, self-directed and w/in 6
years of first academic appointment.* |
| Link: |
Research Scholar Grants |
| *Exception
for research studies in psychosocial, behavioral, health policy or
health services which address cancer health equity and disparities.
Investigators can be at any stage of their career and may request
$400,000/year direct costs for up to 5 years. |
|
|
|
Postdoctoral Fellowships
Support the training of researchers who have received a doctoral degree to
provide initial funding leading to an independent career in
cancer research.
| Amount & Project Period: |
3-year award with progressive stipends of $48,000,
$50,000, and $52,000/year, plus $4,000/year fellowship allowance |
| Eligibility: |
Must be U.S. citizens |
| Link: |
Postdoctoral Fellowships |
|
|
|
Pilot and Exploratory Studies Using Community-Based
Participatory Research (CBPR) to Achieve Cancer Health Equity
To stimulate research on effective interventions to reduce cancer health
disparities (at any stage of the cancer continuum) and achieve
cancer health equity using community-based participatory
research (CBPR).
| Amount & Project Period: |
$100,000 (TOTAL) - 2 years |
| Eligibility: |
Independent investigators at all stages of
career are eligible |
| RFP: |
CBPR Request for Proposals |
|
|
|
Pilot and Exploratory
Projects in Palliative Care of
Cancer Patients and Their Families
Pilot and exploratory research studies whose purpose is to test
interventions, develop research methodologies, and explore novel
areas of research in palliative care of cancer patients and
their families
| Amount & Project Period: |
$60,000/year (Direct Costs) - 2 years |
| Eligibility: |
Independent investigators at all stages of
their career are eligible to apply |
| RFA Link: |
Palliative Care Request for Proposals |
|
|
The Role of Health Policy and Health Insurance in Improving
Access to and Performance of Cancer Prevention, Early Detection,
and Treatment Services
A call for research that evaluates the
impact of the many changes now occurring in the healthcare
system with a particular focus on cancer prevention, control,
and treatment Efforts focusing on improving access to care may
also impact inequities that contribute to health disparities.
| Amount & Project Period: |
$165,000/year (Direct Costs) - 4 years
$200,000/year (Direct Costs) - 5 years (Health Equity focus only) |
| Eligibility: |
Independent investigators at all stages of
their career are eligible to apply |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA |
|
|
| April 01 |
Postdocs |
Non-federal |
Career Development |
Cancer Research Institute
Irvington Post Doctoral Fellowships
Seeks hypothesis driven, mechanistic studies in both immunology
and tumor immunology
| Due Dates: |
March 30 (OSR) Ι April 01 (Sponsor) |
| Amount & Project Period: |
Stipend of:
$50,000 Year 01
$53,000 Year 02
$57,000 Year 03 and
$1,500/year for research support |
| Eligibility: |
Must have doctoral degree by date of award
activation Applicants
>5 or more years of relevant postdoctoral
experience are not eligible; except M.D. applicants, who should not
include years of residency in calculation
No citizenship restrictions |
| Contact: |
Linda
Nolan, x6071 |
| Links: |
CRI Grants and
Programs
Postdoctoral Fellowship Application Guidelines |
|
NEW |
| April 01 |
All faculty |
Non-federal |
Leukemia |
When Everyone Survives (WES) Leukemia Research Foundation
2015 request for Proposals in Leukemia Research
Laboratory, translational, or clinical research related to acute leukemia
| Due Dates: |
March 30 (OSR) Ι April 01 (Sponsor) |
| Amount & Project Period: |
$50,000 (Total) - 1 year |
| Eligibility: |
All Faculty |
| Contact: |
Linda
Nolan, x6071 |
| RFP Link: |
2015 RFP |
|
|
Re-issue of PAR-12-055
NEW FOA Number
|
| April 01 |
All Ranks |
federal |
Health Equity Partnerships |
Comprehensive Partnerships to Advance Cancer Health Equity
(CPACHE)
To continue fostering and supporting intensive collaborations among
investigators at institutions serving underserved health
disparity populations and underrepresented students (ISUPS) and
NCI-designated Cancer Centers (CCs) to develop stronger national
cancer programs aimed at understanding reasons behind
significant cancer disparities and related impacts on these
populations.
| Due Dates: |
March 30 (OSR) Ι April 01 (Sponsor) |
| Amount & Project Period: |
$2.5M/year (Direct Costs) for dyads
$3.0M/year (Direct costs) for triads - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda Nolan (x6071) |
| FOA Link: |
PAR-15-103 |
|
|
NEW
|
| April 09 |
All Ranks |
Federal |
Cancer Care Delivery |
Multilevel Interventions in Cancer Care Delivery: Building
from the Problem of Follow-up to Abnormal Screening Tests
1. Seeks to advance the science of multilevel interventions in 3 ways:
a) By establishing a common
conceptualization of levels & associated level-specific
factors that affect practice;
b) By standardizing metrics of the levels and their main effects on other levels and the
individuals needing follow-up care;
c) By developing and standardizing analysis
of the effect of interventions on individuals,
groups, and organizations responsible for
intervention implementation.
2. Encourages applications that test interventions to
improve the follow-up of abnormal
screening
in one or more ways, including:
a) measuring multilevel effects
of single-level interventions;
b) comparing single vs.
multilevel interventions;
c) testing multilevel
interventions
| Due Dates: |
April 07 (OSR) Ι April 09 (Sponsor) Letter
of Intent due 30 days prior to stated sponsor due date |
| Amount & Project Period: |
$450,000 to $500,000/year (Direct Costs) - 4
years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan, x6071 |
| FOA Link: |
PAR-15-108 |
|
NEW |
| April 14 |
All Faculty |
Non-federal |
Health Disparities |
Robert Wood Johnson Foundation (RWJF)
Awards for Eliminating Health Disparities
Proposals sought to establish annual awards program honoring individuals
who implement systems changes to solve health disparities.
Program will span 7 years w/first winner selected in 2016. 10
organizations will be chosen to administer the awards programs
Organizations must have experience with systems change in one or
more of the following areas that influences health outcomes:
access to quality health care, education, employment, income,
community environment, housing or public safety.
| Due Dates: |
April 10 (OSR) Ι April 14 (Sponsor)
Applicant Web Conference March 25, 2015 (2 p.m. ET)
Register
here. |
| Amount & Project Period: |
$60,000 (Total) - 7 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda
Nolan, x6071 |
| Link: |
Overview |
|
Spring Cycle 2015 |
| April 15 |
Jr Faculty |
Non-federal |
Career Development |
American Cancer Society Institutional Research Grant
(ACS-IRG)
ACS-IRG Pilot Project
Funding Opportunities
Pilot funding opportunities to support junior faculty in
initiating cancer-related research projects that assist them in
competing successfully for national research grants.
| Due Dates: |
April 15 (4:00pm) to
Maureen Ahearn |
| Amount & Project Period: |
$30,000 - 1 year |
| Eligibility: |
Full-time faculty members at Assistant
Member/Assistant Professor level or equivalent are eligible
Must be w/in first 6 years of
initial faculty appointment
May not have any active peer-reviewed funding at time of submission or
award
Research Scientists are eligible to apply. Must be independent and
within two years of a tenure-track appointment |
| Contact: |
Maureen Ahearn (x8824) |
| Links: |
ACS-IRG Application Ι
ACS-IRG Guidelines |
|
|
National Institute of General Medical Sciences
NEW
|
| April 20 (LOI) |
All Ranks |
Federal |
Research Support |
Maximizing Investigators' Research Award (MIRA)
The MIRA is a grant to provide support for all of the research
in an investigator's laboratory that falls within the mission of
NIGMS This FOA will test the feasibility of this grant
mechanism through a pilot program with restricted eligibility
| Due Dates: |
April 20 (Letter of Intent)
Applications: May 18 (OSR) Ι May 20 (Sponsor) |
| Amount & Project Period: |
$750,000/year (Direct Costs) - 5 years |
| Eligibility: |
Targets investigators who received either
>2 R01 equivalent awards or a single award of greater
than $400,000 direct costs, from NIGMS in FY2013 or 2014, and with
support for >1 of
their awards expiring in FY2016 or 2017. Other investigators are
ineligible. Only single PD/PI applications are allowed PD/PIs
must be able to devote 51% research effort to MIRA |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-GM-16-002 |
|
|
| April 21 |
Postdocs/Fellows |
Non-federal |
Career Development |
Multiple Myeloma Research Foundation (MMRF)
Research Fellow Awards
To accelerate development of therapeutic approaches
for myeloma; may include proposals in basic science,
validation, or clinical research
| Due Dates: |
April 17 (OSR) Ι April 21
(Sponsor) |
| Amount & Project Period: |
$75,000 - 1 year |
| Eligibility: |
Ph.D., M.D. or equivalent degree at
post-doctorate, clinical fellow or assistant professor levels and
beginning studies in multiple myeloma field under supervision of a
research mentor |
| Contact: |
Linda
Nolan (x6071) |
| Links: |
MMRF Research Grants Ι
2015 Program Guidelines |
|
NEW |
| May 01 |
All Ranks |
Non-federal |
Cellular and Molecular Imaging in Cancer |
Robarts Research Institute
2015 J. Allyn Taylor International Prize in Medicine
This prize is awarded annually to one or more individuals who
have made significant contributions in basic or clinical
research. The 2015 Prize will be granted to a scientist who has
made outstanding contributions in the area of Cellular
and Molecular Imaging in Cancer
| Due Dates: |
May 01 |
| Amount & Project Period: |
All Ranks |
| Eligibility: |
$25,000 - prize |
| Contact: |
Linda
Nolan (x6071) |
| Link: |
Overview |
|
|
| May 12 |
All Ranks |
Federal |
Prevention-Native Americans |
Interventions for Health Promotion and Disease
prevention in Native American Populations
Develop, adapt, and test the effectiveness of health promotion
and disease prevention interventions in Native American (NA)
populations
| Due Dates: |
May 10 (OSR) Ι May 12
(Sponsor) |
| Amount & Project Period: |
Budgets are not limited - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-14-260 |
|
NEW |
| May 15 (LOI) |
All Ranks |
Federal |
Conference Support - Research Integrity |
FY15 Announcement of the Anticipated Availability of Funds
for Research Conferences on Research Integrity
Conferences or workshops must be designed to provide a forum for
discussion and produce tangible outcomes related to at least one
of the following themes:
1) Responsible conduct of research training;
2) Fostering an environment promoting research
integrity;
3) Prevention of research misconduct;
4) Handling of research misconduct allegations;
5) Whistleblowing;
6) International issues in research integrity;
7) Other topics linked to research integrity and
compliance
| Due Dates: |
May 13 (OSR) Ι May 15 (Sponsor) |
| Amount & Project Period: |
$50,000 - 1 year |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
IR-ORI-15-002 |
|
|
| May 17 (LOI) |
All Faculty |
Federal |
Population Science & Cancer |
Bridging the Gap Between Cancer
Mechanism and Population Science
Any project that poses and addresses a challenging cancer
question that can only be addressed by linking these two ends of
the cancer spectrum -- biological mechanism and population
| Due Dates: |
May 17 (Letter of Intent) (also Oct. 4th)
June 15 (OSR) Ι June 17 (Sponsor) (also Nov. 4th) |
| Amount & Project Period: |
$750,000/yr. (Direct Costs) - 5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-13-081 |
|
|
National Center for
Complementary and
Integrative Health
NEW
|
| May 22 (LOI) |
All Ranks |
Federal |
Natural Product Testing |
Phased Innovation Award for Exploratory Clinical Trials of
Natural Products in NCCIH High Priority Research Topics
Supports pilot testing of natural products (i.e., botanicals,
dietary supplements, and probiotics), having sufficient
early-stage data to justify further clinical testing. Intention
is to speed translation of emerging basic science findings about
natural products into clinical pilot testing to determine
whether continued clinical research is warranted
| Due Dates: |
May 22 (Letter of Intent)
Applications: June 18 (OSR) Ι June 22 (Sponsor) |
| Amount & Project Period: |
$275,000 (Total Direct Costs) - 2 years (R21)
$450,000 (Total Direct Costs) - 3 years (R33) |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-AT-16-001 |
|
and
|
Exp. May 28
Int. June 03 |
All Ranks |
Federal |
Healthcare Research |
National Science Foundation & National Institutes of Health
Smart and Connected Health (SCH)
The goal of this interagency program is development of next generation
health and healthcare research through high-risk, high-reward
advances in understanding of and applications in information
science, technology, behavior, cognition, sensors, robotics,
bio-imaging, and engineering. Collaboration between academic,
industry, non-profit and other organizations is strongly
encouraged to establish better linkages between fundamental
science, clinical practice and technology development,
deployment and use.
| Due Dates: |
Exploratory:
May 26 (OSR) Ι May 28 (Sponsor)
Integrative: June 1
(OSR) Ι June 03 (Sponsor)
|
| Amount & Project Period: |
Exploratory:
$170,000/year (Direct Costs) - 3 years
Integrative: $370,000/year (Direct Costs) - 4 years
|
| Eligibility: |
All Ranks - An investigator may participate as
PI, co-PI, Project Director, Senior Personnel or Consultant in no more
than two proposals submitted in response to this solicitation. |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
NSF-13-543 |
|
|
National Center for Complementary and Integrative Health
NEW
|
| May 29 (LOI) |
All Ranks |
Federal |
Natural Product Testing |
Exploratory Clinical Trials and Studies of Natural Products
in NCCIH High Priority Research Topics
Support provided to confirm link between impact of natural
product on biological signature (i.e., mechanism of action) and
demonstrate an association between change in the biological
signature and clinical outcomes. Intention is to speed
translation of emerging basic science findings about natural
products into clinical pilot testing to determine whether
continued clinical research is warranted
| Due Dates: |
May 29 (Letter of Intent)
Applications: June 25 (OSR) Ι June 29 (Sponsor) |
| Amount & Project Period: |
$450,000 (Total Direct Costs) - 3 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| RFA Link: |
RFA-AT-16-002 |
|
|
| May 29 |
All Ranks |
Non-federal |
Drug Discovery |
Sanford Ι Burnham Medical Research Institute
Florida Translational Research Program
2015 Spring Call for Submissions
Concept or assay development
projects for use in pre-therapeutic discovery via
high-throughput screening - development of
innovative biochemical and cell-based assays for biological
targets, pathways, or processes for which there are limited
selective and potent small molecule modulators available
High-throughput screening
(HTS)-ready assays - well-developed, HTS-ready
assays suitable for high-throughput screening of the
Sanford-Burnham library of compounds for the purpose of
identifying small-molecule modulators of the target,
pathways, or processes of interest
Validated hits for the discovery of pre-therapeutic lead
compounds - proposals that aim to further
research and development of existing small-molecule chemical
scaffolds for use in vivo
| Due Dates: |
May 27 (OSR) Ι May 29 (Sponsor) |
| Amount & Project Period: |
No funding - 1 year Provides access to
technological resources for drug development facilitating an
interdisciplinary, collaborative approach to the establishment of a
pipeline of potential new treatments for today's most challenging and
unmet medical needs |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| Link: |
Florida Translational Research Program at Sanford-Burnham |
|
|
| May 29 |
All Ranks |
Federal |
Equipment |
Shared Instrumentation Grant (SIG) Program
Encourages applications from groups of NIH-supported
investigators to purchase or upgrade a single item of expensive,
specialized, commercially available instruments or integrated
systems Types of instruments supported include: X-ray
diffraction systems, nuclear magnetic resonance (NMR) and mass
spectrometers, DNA and protein sequencers, biosensors, electron
and confocal microscopes, cell-sorters, and biomedical imagers
| Due Dates: |
May 27 (OSR) Ι May 29 (Sponsor) |
| Amount & Project Period: |
Maximum: $600,000 - 1 year |
| Eligibility: |
PD/PI should have documented technical
expertise directly related to chosen instrument.
Major User group of 3 or more individuals must be identified. Each must
be a PD/PI on a distinct NIH award with one of the following activity
codes: R01, DP1, DP2, P01, P50, R37, and U01. Major Users must have
substantial interests in and needs for the instrument.
Major Users can be researchers from the same department or from several
departments, divisions or schools at applicant institution, or from
nearby or regional institutions. |
| Contact: |
Christi Craig (x1458) |
| FOA Link: |
PAR-15-088 |
|
|
| June 01 |
All Ranks |
Non-federal |
Pediatric Brain Cancer |
The Cure Starts Now Foundation
Research Grants
Funds search for a cure for brainstem glioma and other forms of
pediatric brain cancer in the hopes of curing all cancers Focus
is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support
translational and clinical research projects in those areas.
| Due Dates: |
May 28 (OSR) Ι June 01 (Sponsor) (Hardcopy
by June 5th) |
| Amount & Project Period: |
$100,000 - 1 year |
| Eligibility: |
All Ranks |
| Contact: |
Shaina
Sine (x3658) |
| Link: |
Research & Grants |
|
NEW FOA # |
| June 17 |
All Ranks |
federal |
Health Disparities |
Exploratory/Developmental Grants Program for Basic Cancer
Research in Cancer Health Disparities
Basic research studies into the biological/genetic causes and
mechanisms of cancer health disparities
| Due Dates: |
June 15 (OSR) Ι June 17 (Sponsor) |
| Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-15-092 |
|
NEW FOA # |
| June 17 |
All Ranks |
federal |
Health Disparities |
Basic Cancer Research in Cancer Health Disparities
To investigate biological/genetic bases of cancer disparities,
such as (1) mechanistic studies of biological factors associated
with cancer disparities, including those related to basic
research in cancer biology or cancer prevention intervention
strategies, (2) development & testing of new methodologies &
models, and (3) secondary data analyses
| Due Dates: |
June 15 (OSR) Ι June 17 (Sponsor) |
| Amount & Project Period: |
$250,000 (Direct Costs) - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| PAR Link: |
PAR-15-093 |
|
NEW FOA # |
| June 22 |
All Ranks |
Federal |
Career Development |
Exploratory Grant Award to Promote Workforce Diversity in
Basic Cancer Research
Supports eligible investigators from groups that have been shown
to be underrepresented in the biomedical, clinical, behavioral,
and social sciences workforce. Provides a bridge to
investigators that have completed their research training and
may need extra time to develop a larger research project grant
application.
| Due Dates: |
June 18 (OSR) Ι June 22 (Sponsor) |
| Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-15-053 |
|
|
| June 30 |
All Ranks |
Non-federal |
Leukemia | \
Children's Leukemia Research Association, Inc.
Research Grants
Funds the most promising studies to isolate the causes of
leukemia
| Due Dates: |
June 26 (OSR) Ι June 30 (Sponsor) |
| Amount & Project Period: |
$30,000 - 1 year |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| Link: |
Research
Grants |
|
NEW |
| July 01 |
Jr. Faculty |
Non-federal |
Career Development |
Damon Runyon Cancer Research Institute
Innovation Award
To provide funding to extraordinary early career researchers who have an
innovative new idea but lack sufficient preliminary data to
obtain traditional funding
| Due Dates: |
June 29 (OSR) Ι July 01 (Sponsor)
by 4:00pm ET |
| Amount & Project Period: |
$150,000/year - 2 years (w/opportunity for up
to 2 addnl. years) |
| Eligibility: |
Applicants must belong to one
of the following:
Tenure-track Assistant
Professors w/in first 4 years of initial
Assistant Professor position (Cut-off date: July 1,
2011.)
Clinical Instructors and
Senior Clinical Fellows (in final year of
sub-specialty training) holding an MD and pursuing a
period
of independent research before a tenure-track faculty
position.
Applicants are expected
to commit a minimum of 80% FTE to
conducting research |
| Contact: |
Linda
Nolan (x6071) |
| Links: |
Overview Ι
Application Guidelines |
|
